Lorvotuzumab (anti-CD56)
- CAS No.
- 339306-30-8
- Chemical Name:
- Lorvotuzumab (anti-CD56)
- Synonyms
- lorvotuzumab;Lorvotuzumab (anti-CD56)
- CBNumber:
- CB213975623
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
- TDS File:
- TDS
Lorvotuzumab (anti-CD56) price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0623906 | Lorvotuzumab 99.77% | 339306-30-8 | 1mg | $412 | 2026-06-04 | Buy |
| ChemScene | CS-0623906 | Lorvotuzumab 99.77% | 339306-30-8 | 5mg | $1062 | 2026-06-04 | Buy |
| ChemScene | CS-0623906 | Lorvotuzumab 99.77% | 339306-30-8 | 10mg | $1690 | 2026-06-04 | Buy |
| Biorbyt Ltd | orb1290236 | Lorvotuzumab >95% | 100μg | $240 | 2026-05-06 | Buy | |
| Biorbyt Ltd | orb1290236 | Lorvotuzumab >95% | 1mg | $820 | 2026-05-06 | Buy |
Lorvotuzumab (anti-CD56) Chemical Properties, Uses, Production
Uses
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1].
References
[1] James I Geller, et al. ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study. Cancer. 2020 Dec 15;126(24):5303-5310. DOI:10.1002/cncr.33195
Lorvotuzumab (anti-CD56) Preparation Products And Raw materials
Raw materials
Preparation Products
Lorvotuzumab (anti-CD56) Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 | psaitong@jm-bio.com | China | 27626 | 58 |
| Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11963 | 58 |
| Wuhan Acumen Bio-Technology Co.,ltd | 027-027-16602739303 16602739303 | 673003916@qq.com | China | 4593 | 58 |
| Shanghai Aladdin Biochemical Technology Co.,Ltd. | 6206333 13167063860 | anhua.mao@aladdin-e.com | China | 43439 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| Shanghai Amole Biotechnology Co., Ltd. | 13370042665 18916960931 | 2596183085@qq.com | China | 17234 | 58 |
| Wuhan Maixi Biotechnology Co., Ltd | 18007167883 18007167883 | Service@mabnus.com | China | 921 | 58 |
| Aladdin Scientific | tp@aladdinsci.com | United States | 54738 | 58 |
View Latest Price from Lorvotuzumab (anti-CD56) manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-09-10 | Lorvotuzumab
339306-30-8
|
$313.00-1290.00 | > 95% | 10g | TargetMol Chemicals Inc. |
-
- Lorvotuzumab
339306-30-8
- $313.00-1290.00
- > 95%
- TargetMol Chemicals Inc.
